echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medicines Company News > Bei lu pharmaceutical industry to Yu Hengrui to grab the first imitation! The 15 billion-year-old imager market is back on the ups and downs.

    Bei lu pharmaceutical industry to Yu Hengrui to grab the first imitation! The 15 billion-year-old imager market is back on the ups and downs.

    • Last Update: 2020-10-28
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Pharmaceutical network October 19 days ago, CDE official website shows that Beijing Bei lu pharmaceutical industry's lumen injection imitation 4 types of listing applications were accepted.
    meters intranet data show that in 2019 China's public medical institutions terminal imager sales of more than 15 billion yuan, in the product TOP20, the injection of niobol ranked 18th, the manufacturer of only Bayer.
    has grown rapidly in recent years, with growth of more than 70% in 2019.
    , Jiangsu Hengrui Pharmaceutical's niobol injections were submitted for listing in a generic category of 4.
    Source: One-click access to MiNet data show that in recent years, China's urban public hospitals, county-level public hospitals, urban community centers and township hospitals (China's public medical institutions) terminal shadow agent sales growth rate of more than 10%, in 2019 has exceeded 15 billion yuan.
    18th place in the TOP20, a product with only one Bayer manufacturer, with sales up more than 70% year-on-year in 2019.
    source: MED2.0 China Drug Review Database Up to now, the injection of niobol has Beijing Beiland Pharmaceuticals and Jiangsu Hengrui Pharmaceuticals to copy 4 categories of applications submitted for listing, in the review and approval (in the drug review center), after approval will be treated as a consistent evaluation.
    data sources: CDE official website, Mienet database.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.